GFS
BIIB icon

GYL Financial Synergies’s Biogen BIIB Stock Holding History

GYL Financial Synergies’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-620
Closed -$215K – 189
2021
Q2 		$215K Buy
+620
New +$188K 0.11% 174
2020
Q4 		– Sell
-730
Closed -$207K – 171
2020
Q3 		$207K Buy
+730
New +$204K 0.14% 151
2020
Q2 		– Sell
-995
Closed -$315K – 152
2020
Q1 		$315K Hold
995
– – 0.2% 98
2019
Q4 		$295K Buy
995
+116
+13% +$32.2K 0.13% 128
2019
Q3 		$205K Hold
879
– – 0.1% 164
2019
Q2 		$206K Sell
879
-2
-0.2% -$462 0.11% 153
2019
Q1 		$208K Sell
881
-6
-0.7% -$1.89K 0.12% 152
2018
Q4 		$267K Buy
+887
New +$283K 0.19% 103

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GYL Financial Synergies's BIIB Position: Q3 2021 in Review

GYL Financial Synergies sold out of Biogen (BIIB) in Q3 2021, closing a stake of 620 shares — an estimated $215K sold.

GYL Financial Synergies first reported a position in BIIB in Q4 2018 and held it in 8 quarters. The position peaked at $315K in Q1 2020. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • GYL Financial Synergies reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • GYL Financial Synergies sold 620 Biogen shares in Q3 2021, an estimated $215K.
  • GYL Financial Synergies first reported a position in Biogen in Q4 2018 and held it in 8 quarters.
  • GYL Financial Synergies's Biogen position peaked at $315K in Q1 2020.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on GYL Financial Synergies's 13F filing for Q3 2021, filed 1 Nov 2021.